Who is sponsoring NCT03669796?

NCT03669796 is sponsored by Helse Møre og Romsdal HF.

What drugs are being tested in NCT03669796?

Interventions in NCT03669796: Marine protein hydrolysate (mph), Control.

What condition does NCT03669796 study?

NCT03669796 studies Healthy Volunteers.

Is NCT03669796 still recruiting?

NCT03669796 is currently completed. Last updated 14 November 2019.

Last reviewed 2019-11-14 · How we verify

NCT03669796: MPH-BS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Marine Protein Hydrolysate as Dietary Supplement in Elderly Part I

Completed NA Last updated 14 November 2019

What this trial tests

NA trial testing Marine protein hydrolysate (mph) in Healthy Volunteers in 41 participants. Completed in 28 February 2018.

Timeline

27 November 2017

Primary endpoint
28 February 2018

28 February 2018

Quick facts

Lead sponsor	Helse Møre og Romsdal HF
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	basic science
Enrollment	41
Start date	27 November 2017
Primary completion	28 February 2018
Estimated completion	28 February 2018
Sites	2 locations across Norway

Drugs / interventions tested

Marine protein hydrolysate (mph)
Control

Conditions studied

Healthy Volunteers — all drugs for Healthy Volunteers →

Sponsor

Helse Møre og Romsdal HF — full company profile →

Who can join

Adults 40 to 65, any sex, with Healthy Volunteers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the potential effect of a marine protein hydrolysate (MPH) supplement before a meal on postprandial glucose tolerance in healthy subjects, to achieve more knowledge on this presumed beneficial, blood glucose lowering effect

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Effect of a cod protein hydrolysate on postprandial glucose metabolism in healthy subjects: a double-blind cross-over trial.
Dale HF, Jensen C, Hausken T, Lied E, et al · · 2018 · cited 25× · PMID 30524707 · DOI 10.1017/jns.2018.23
Acute effect of a cod protein hydrolysate on postprandial acylated ghrelin concentration and sensations associated with appetite in healthy subjects: a double-blind crossover trial.
Dale HF, Jensen C, Hausken T, Lied E, et al · · 2019 · cited 4× · PMID 31692759 · DOI 10.29219/fnr.v63.3507

Verify or expand the search:

Other recruiting trials for Healthy Volunteers

Currently open trials in the same condition.

NCT07504003 — Influence of Training Session Duration on Improvements in Physiological Resilience to Exercise · NA · recruiting
NCT07446400 — A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuva · Phase 1 · recruiting
NCT07495813 — A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease · Phase 1 · recruiting
NCT07499050 — A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity · Phase 1 · recruiting
NCT07342114 — A Dose-Escalation Study of RO7875913 in Healthy Participants · Phase 1 · recruiting

Other Helse Møre og Romsdal HF trials

Trials by the same sponsor.

NCT07381790 — Modern Technologies in Lower Respiratory Tract Infections in Children · recruiting
NCT07021274 — DBT Skill Training for Autistic Adults With Difficulties in Emotion Regulation. · NA · not yet recruiting
NCT06458374 — ATTR Cardiac Amyloidosis in a Selected Population · recruiting
NCT06507046 — The personalKNEE Trial · NA · recruiting
NCT06499038 — The Ace Avanteon Study - A Randomized Controled Trial · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03669796 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Helse Møre og Romsdal HF
Last refreshed: 14 November 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03669796.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing